Eun Yeong Cho1, Ki Jong Oh2, Chin Kook Rhee3, Kwang Ha Yoo4, Bo Yeon Kim5, Hye Won Bae5, Byung-Jae Lee6, Dong-Chull Choi6, Hyun Lee7, Hye Yun Park1. 1. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. 2. Division of Pulmonology, Department of Internal Medicine, Chamjoeun Hospital, Gwangju, South Korea. 3. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea. 4. Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, South Korea. 5. Health Insurance Review & Assessment Service, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. 6. Division of Allergy, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. 7. Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Abstract
BACKGROUND: Data on the clinical characteristics of asthma patients including utilization of medical facilities, disease management, and healthcare costs by types of health care are insufficient. METHODS: We evaluated data on 729,343 asthma patients from the Health Insurance Review and Assessment Service (HIRA) database of Korea between July 2013 and June 2014. RESULTS: Most asthma patients were treated via primary care (81.7%), followed by tertiary (17.8%) and secondary (0.5%) care. Patients requiring secondary or tertiary care exhibited more comorbidities and exacerbations than those treated via primary care, and utilized more medical facilities (associated with higher medical costs). The prescription rate of leukotriene receptor antagonists (LTRAs) was relatively high for those receiving all types of health care, ranging from 62% to 78%. However, the prescription rate of inhalants containing corticosteroids was significantly lower in patients treated via primary care than those receiving secondary or tertiary care (P<0.001). In addition, pulmonary function testing (PFT) was performed less often in patients treated via primary care than in those receiving secondary or tertiary care (P<0.001). CONCLUSIONS: Most patients with asthma were treated via primary care; however, those receiving secondary or tertiary care exhibited substantial utilization of medical facilities with high costs. Diagnostic measures and the prescription of inhalants containing corticosteroids in primary care require urgent attention.
BACKGROUND: Data on the clinical characteristics of asthma patients including utilization of medical facilities, disease management, and healthcare costs by types of health care are insufficient. METHODS: We evaluated data on 729,343 asthma patients from the Health Insurance Review and Assessment Service (HIRA) database of Korea between July 2013 and June 2014. RESULTS: Most asthma patients were treated via primary care (81.7%), followed by tertiary (17.8%) and secondary (0.5%) care. Patients requiring secondary or tertiary care exhibited more comorbidities and exacerbations than those treated via primary care, and utilized more medical facilities (associated with higher medical costs). The prescription rate of leukotriene receptor antagonists (LTRAs) was relatively high for those receiving all types of health care, ranging from 62% to 78%. However, the prescription rate of inhalants containing corticosteroids was significantly lower in patients treated via primary care than those receiving secondary or tertiary care (P<0.001). In addition, pulmonary function testing (PFT) was performed less often in patients treated via primary care than in those receiving secondary or tertiary care (P<0.001). CONCLUSIONS: Most patients with asthma were treated via primary care; however, those receiving secondary or tertiary care exhibited substantial utilization of medical facilities with high costs. Diagnostic measures and the prescription of inhalants containing corticosteroids in primary care require urgent attention.
Authors: R de Marco; V Cappa; S Accordini; M Rava; L Antonicelli; O Bortolami; M Braggion; M Bugiani; L Casali; L Cazzoletti; I Cerveri; A G Fois; P Girardi; F Locatelli; A Marcon; A Marinoni; M G Panico; P Pirina; S Villani; M E Zanolin; G Verlato Journal: Eur Respir J Date: 2011-10-17 Impact factor: 16.671
Authors: Chin Kook Rhee; Hyoung Kyu Yoon; Kwang Ha Yoo; Young Sam Kim; Sei Won Lee; Yong Bum Park; Jin Hwa Lee; Yuri Kim; Kyungjoo Kim; Jinhee Kim; Yeon Mok Oh; Sang Do Lee Journal: COPD Date: 2013-10-10 Impact factor: 2.409
Authors: Mohsen Sadatsafavi; Larry Lynd; Carlo Marra; Bruce Carleton; Wan C Tan; Sean Sullivan; J Mark Fitzgerald Journal: Can Respir J Date: 2010 Mar-Apr Impact factor: 2.409
Authors: Rosa Munoz-Cano; Alfons Torrego; Joan Bartra; Jaime Sanchez-Lopez; Rosa Palomino; Cesar Picado; Antonio Valero Journal: Eur Respir J Date: 2017-03-02 Impact factor: 16.671